Publications by authors named "Dev Samarasinghe"

Claim this Profile
E
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
Astrid-Jane Greenup, Pok Kern Tan, Vi Nguyen, Anne Glass, Scott Davison, Dev Samarasinghe

J Hepatol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
Archana Sud, Jason M Hui, Geoffrey C Farrell, Priyanka Bandara, James G Kench, Dev Samarasinghe

Hepatology· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
Shirley A Coverdale, Mahbub H Khan, Karen Byth, Rita Lin, Martin Weltman, Dev Samarasinghe

Am J Gastroenterol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
Shirley A Coverdale, Dev A Samarasinghe, Rita Lin, James Kench, Karen Byth

Am J Gastroenterol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting.
Dinesh Kumar, Craig Wallington-Beddoe, Jacob George, Rita Lin, Dev Samarasinghe

Med J Aust· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Shivakumar Chitturi, Geoffrey Farrell, Linda Frost, Adamandia Kriketos, Rita Lin, Dev Samarasinghe

Hepatology· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
Jason M Hui, James Kench, Geoffrey C Farrell, Rita Lin, Dev Samarasinghe

J Gastroenterol Hepatol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Shivakumar Chitturi, Martin Weltman, Geoffrey C Farrell, David McDonald, James Kench, Dev Samarasinghe

Hepatology· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.
Jason M Hui, Jacob George, Christopher Liddle, Rita Lin, Dev Samarasinghe

Am J Gastroenterol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C Farrell, Jane Holmes-Walker, Jason M Hui, Dev Samarasinghe

Hepatology· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis